Repurposing Candesartan Cilexetil as Antibacterial Agent for MRSA Infection

Repurposing Candesartan Cilexetil as Antibacterial Agent for MRSA Infection

Staphylococcus aureus is an important pathogen causing hospital-acquired infections. Methicillin-resistant S. aureus (MRSA), biofilms, and persisters are highly tolerant to traditional antibiotics and make it difficult to treat. Therefore, new antimicrobial agents are urgently needed to treat hard-t...

Full description

Bibliographic Details
Main Authors:	Lanlan Xu, Pengfei She, Lihua Chen, Shijia Li, Linying Zhou, Zubair Hussain, Yaqian Liu, Yong Wu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-09-01
Series:	Frontiers in Microbiology
Subjects:	candesartan cilexetil Staphylococcus aureus antibacterial synergistic resistance biofilm
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2021.688772/full

Similar Items

Formulation and Bioavailability of Novel Mucoadhesive Buccal Films for Candesartan Cilexetil in Rats
by: Omar Y. Mady, et al.
Published: (2021-08-01)

Candesartan Cilexetil In Vitro–In Vivo Correlation: Predictive Dissolution as a Development Tool
by: Andrés Figueroa-Campos, et al.
Published: (2020-07-01)

Response surface based optimization of system variables for liquid chromatographic analysis of candesartan cilexetil
by: Jagdish V. Manwar, et al.
Published: (2017-01-01)

Novel Combination for Self-Nanoemulsifying Drug Delivery System of Candesartan Cilexetil
by: Safa F. Mekhilef, et al.
Published: (2018-12-01)

Oral nanoemulsions of candesartan cilexetil: formulation, characterization and in vitro drug release studies
by: Halah Hussein Ali, et al.
Published: (2017-06-01)

Effects of combination of AT1-antagonist candesartan cilexetil and ASE-inhibitors in patients with congestive heart failure
by: Gašanin Edis, et al.
Published: (2013-01-01)

Enhancing the Oral Bioavailability of Candesartan Cilexetil Loaded Nanostructured Lipid Carriers: In Vitro Characterization and Absorption in Rats after Oral Administration
by: Walid Anwar, et al.
Published: (2020-10-01)

Development and validation of a dissolution test with reversed-phase high performance liquid chromatographic analysis for Candesartan cilexetil in tablet dosage forms
by: Vairappan Kamalakkannan, et al.
Published: (2016-09-01)

Candesartan Cilexetil Attenuates Arrhythmogenicity Following Pressure Overload in Rats via the Modulation of Cardiac Electrical and Structural Remodeling and Calcium Handling Dysfunction
by: Gwo‐Jyh Chang, et al.
Published: (2022-08-01)

Developing pH-Modulated Spray Dried Amorphous Solid Dispersion of Candesartan Cilexetil with Enhanced In Vitro and In Vivo Performance
by: Surendra Poudel, et al.
Published: (2021-04-01)

Differential clinical profile of candesartan compared to other angiotensin receptor blockers
by: Zimlichman R
Published: (2011-12-01)

Preparation of Candesartan and Atorvastatin Nanoparticles by Solvent Evaporation
by: Josef Jampilek, et al.
Published: (2012-11-01)

Repurposing Antispasmodic Agent Otilonium Bromide for Treatment of Staphylococcus aureus Infections
by: Linying Zhou, et al.
Published: (2020-07-01)

Identification of new process-related impurity in the key intermediate in the synthesis of TCV-116
by: Testen Ana, et al.
Published: (2019-03-01)

Repurposing Eltrombopag as an Antimicrobial Agent Against Methicillin-Resistant Staphylococcus aureus
by: Pengfei She, et al.
Published: (2022-01-01)

Oral solid self-nanoemulsifying drug delivery systems of candesartan citexetil: formulation, characterization and in vitro drug release studies
by: Halah Hussein Ali, et al.
Published: (2017-06-01)

Candesartan in treating hypertension
by: L O Minushkina
Published: (2014-03-01)

Solid State Stability and Kinetics of Degradation for Candesartan—Pure Compound and Pharmaceutical Formulation
by: Valentina Buda, et al.
Published: (2020-01-01)

Repurposing of the antimalarial agent tafenoquine to combat MRSA
by: Pengfei She, et al.
Published: (2023-12-01)

Drug repurposing: insights into the antimicrobial effects of AKBA against MRSA
by: Yingjia Li, et al.
Published: (2024-01-01)

Evaluation of Antibacterial and Antibiofilm Activity of Biogenic Silver Nanoparticles and Gentamicin Against Staphylococcus aureus Isolated from Caprine Mastitis
by: Ali H AL-Dujaily, et al.
Published: (2022-06-01)

CANDESARTAN IN CARDIOLOGY PRACTICE
by: N. A. Dzhaiani
Published: (2017-12-01)

Synergistic antibacterial activity between penicillenols and antibiotics against methicillin-resistant Staphylococcus aureus
by: Shuihong Li, et al.
Published: (2018-01-01)

Synergistic combinations of antimicrobial peptides against biofilms of methicillin-resistant Staphylococcus aureus (MRSA) on polystyrene and medical devices
by: Eleonora Ciandrini, et al.
Published: (2020-06-01)

Antibacterial Effect of Zataria multiflora Extract on MRSA
by: Maryam Motevasel, et al.
Published: (2014-11-01)

The Inhibition Effect of Linezolid With Reyanning Mixture on MRSA and its Biofilm is More Significant than That of Linezolid Alone
by: Lulu Zhang, et al.
Published: (2022-01-01)

Synergistic Microbicidal Effect of Auranofin and Antibiotics Against Planktonic and Biofilm-Encased S. aureus and E. faecalis
by: Pengfei She, et al.
Published: (2019-10-01)

Corrigendum: Synergistic Microbicidal Effect of Auranofin and Antibiotics Against Planktonic and Biofilm-Encased S. aureus and E. faecalis
by: Pengfei She, et al.
Published: (2021-06-01)

No pharmacokinetic interactions between candesartan and amlodipine following multiple oral administrations in healthy subjects
by: Kim JR, et al.
Published: (2018-08-01)

The comparison between combination of candesartan-amlodipine and candesartan-furosemide on blood pressure in hypertensive patients with chronic kidney disease
by: Dian Ayu Juwita, et al.
Published: (2022-07-01)

Cost Effectiveness Kombinasi Antihipertensi Candesartan-Bisoprolol dan Candesartan-Amlodipin Pada Pasien Rawat Jalan Penderita Hipertensi
by: Eny Nurhikma, et al.
Published: (2019-12-01)

Candesartan in the prevention of cardiovascular catastrophes: emphasis on the pre-vention of stroke
by: Oksana Mikhaylovna Drapkina, et al.
Published: (2009-12-01)

Evaluation of the effectiveness of candesartan, diltiazem, or their combination on normo-, micro- and macroalbuminuria in type 2 diabetic patients
by: Jawad H. Ahmed, et al.
Published: (2013-12-01)

Antibacterial Activity of Protocatechuic Acid Ethyl Ester on Staphylococcus aureus Clinical Strains Alone and in Combination with Antistaphylococcal Drugs
by: Maria Miklasińska, et al.
Published: (2015-07-01)

In vitro and in vivo Evaluation of the Bioactive Nanofibers-Encapsulated Benzalkonium Bromide for Accelerating Wound Repair with MRSA Skin Infection
by: Ran L, et al.
Published: (2022-09-01)

Candesartan cilexetil in cardiovascular prevention
by: A. Ya. Ivleva
Published: (2007-12-01)

Biorelevant dissolution of candesartan cilexetil
by: Lucie Gruberová, et al.
Published: (2017-03-01)

Intoxication with massive doses of amlodipine and candesartan requiring venoarterial extracorporeal membrane oxygenation
by: Minagawa Yusuke, et al.
Published: (2023-01-01)

The benefits of candesartan usage in the treatment of arterial hypertension
by: O D Ostroumova, et al.
Published: (2014-06-01)

Daily Administered Dual-Light Photodynamic Therapy Provides a Sustained Antibacterial Effect on <i>Staphylococcus aureus</i>
by: Sakari Nikinmaa, et al.
Published: (2021-10-01)